medical guideline

首页 肿瘤学指南 症状管理 详情

Definition of Episodic Dyspnea in Cancer Patients: a Delphi-based Consensus Among Spanish Experts: the INSPIRA Study

原文:2019年 发布于 Journal of Palliative Medicine 22卷 第4期 413-419 浏览量:319 原文链接

作者:

归属分类: 所属人体系统: 其他 | 分类: 症状管理

关键词: Breathlessness Cancer Dyspnea Episodic Dyspnea Consensus

指南简介

Background: Episodic dyspnea is an increasingly recognized phenomenon that occurs frequently in patients with cancer. Although numerous definitions have been proposed to describe episodic dyspnea, to date, no common widely accepted definition in Spanish has yet emerged. Without a clear well-accepted definition, it is difficult to design rigorous clinical trials to evaluate candidate treatments for this emerging entity and to compare outcomes among studies.

Objective: The aim of the study was to reach a consensus definition of episodic dyspnea in the Spanish language based on professional criteria in cancer patients.

Design: A two-round Delphi study.

Setting/subjects: Sixty-one Spanish specialists in medical oncology, radiation oncology, pneumology, palliative care, and pain management participated in the study.

Measurements: Sixteen different questions on dyspnea-related terminology, including the definition of episodic dyspnea, were assessed.

Results: The panel of experts reached a consensus on 75% of the 16 assessments proposed: 56.25% in agreement and 18.75% in disagreement. The term that most panelists considered most appropriate to define dyspnea exacerbation was dyspnea crisis. The panelists disagreed that dyspnea exacerbation is equivalent to dyspnea at effort and that the presence of dyspnea at rest is required for exacerbation to occur. However, there was wide agreement that exacerbation may or may not be predictable and can be triggered by comorbidities as well as emotional, environmental, or effort factors.

Conclusions: The broad consensus reached in this study is a necessary first step to design high-quality methodological studies to better understand episodic dyspnea and improve treatment.